The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Gilles de la Tourette's Disease—A Review

Published Online:https://doi.org/10.1176/ajp.131.9.1000

The author describes Gilles de la Tourette's disease, noting that it is characterized by sudden involuntary movements, explosive involuntarty utterances, and imitative phenomena; the pathognomonic feature is the sudden, uncontrolled repetitive utterance of obscenities. The general progression of symptoms is cephalocaudad, with frequent waxing and waning; symptoms become worse during affective arousal and improve with relaxation. Etiology is unclear, with recent evidence suggesting catecholaminergic overactivity. Although this disease and schizophrenia are clearly two separate entities, the author suggests that Gilles de la Tourette's disease may be behaviorally related to schizophrenia and biochemically related to the amphetamine psychosis. The treatment of choice is haloperidol.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.